Quarterly Transactions Made in Inhibikase Therapeutics, Inc. (IKT)
This table provides information about the institutional ownership of Inhibikase Therapeutics, Inc. (IKT). The information is specifically focused on institutions that hold shares of Inhibikase Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q4 2020 | 0 | 30,050 | 30,050 | — | 30,050 | |||
| Q1 2021 | 0 | 12,169 | 12,169 | 0 | 11,250 | 11,250 | 919 | |
| Q2 2021 | 78,386 | 3,685,882 | 3,764,268 | 0 | 543 | 543 | 3,763,725 | |
| Q3 2021 | 237,183 | 153,964 | 391,147 | 64,000 | 124,749 | 188,749 | 202,398 | |
| Q4 2021 | 137,250 | 685,539 | 822,789 | 120,295 | 40,383 | 160,678 | 662,111 | |
| Q1 2022 | 62,027 | 301,073 | 363,100 | 512,024 | 234,755 | 746,779 | -383,679 | |
| Q2 2022 | 163,284 | 100,877 | 264,161 | 200,356 | 988,365 | 1,188,721 | -924,560 | |
| Q3 2022 | 154,000 | 67,547 | 221,547 | 112,816 | 0 | 112,816 | 108,731 | |
| Q4 2022 | 68,158 | 79,703 | 147,861 | 104,087 | 0 | 104,087 | 43,774 | |
| Q1 2023 | 65,836 | 3,096,247 | 3,162,083 | 8,012 | 0 | 8,012 | 3,154,071 | |
| Q2 2023 | — | 69,015 | 0 | 69,015 | -69,015 | |||